Benzinga | Feb 23, 2021 04:20PM EST

Theravance Biopharma Q4 EPS $(0.92) Beats $(1.02) Estimate, Sales $18.73M Miss $20.85M Estimate

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.92) per share which beat the analyst consensus estimate of $(1.02) by 9.8 percent. This is a 21.37 percent increase over losses of $(1.17) per share from the same period last year. The company reported quarterly sales of $18.73 million which missed the analyst consensus estimate of $20.85 million by 10.17 percent. This is a 36.51 percent decrease over sales of $29.50 million the same period last year.